Literature DB >> 10644960

Production of porous hydroxyapatite by the gel-casting of foams and cytotoxic evaluation.

P Sepulveda1, J G Binner, S O Rogero, O Z Higa, J C Bressiani.   

Abstract

This study presents the manufacture of highly porous hydroxyapatite by a novel technique that employs the foaming of suspensions prior to the in situ polymerization of organic monomers contained in the compositions. This method produces strong gelled bodies with up to 90% porosity that can withstand machining in the green state. Complex-shaped components can be obtained if the process comprises casting in one of the processing steps. The organic additives are eliminated at temperatures above 300 degrees C, and sintering is carried out for consolidation of the ceramic matrix. Spherical interconnected cells with sizes ranging from 20 to 1000 micrometer characterize the porous structure, depending on the specimen density. Cytotoxicity tests were conducted on extracts from sintered HA foams based on a quantitative method of cell colony formation and the determination of cell death after indirect contact of the porous material with mammalian cells. This in vitro test of biological evaluation revealed that the original purity of the biomedical-grade hydroxyapatite powder was affected neither through processing nor by the employed reagents. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644960     DOI: 10.1002/(sici)1097-4636(200004)50:1<27::aid-jbm5>3.0.co;2-6

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  18 in total

1.  Effects of alkali pretreatment of silk fibroin on microstructure and properties of hydroxyapatite-silk fibroin nanocomposite.

Authors:  Li Wang; Rei Nemoto; Mamoru Senna
Journal:  J Mater Sci Mater Med       Date:  2004-03       Impact factor: 3.896

2.  Synthesis of porous hydroxyapatites by combination of gelcasting and foams burn out methods.

Authors:  S Padilla; J Román; M Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

3.  Microstructural and in vitro characterization of SiO2-Na2O-CaO-MgO glass-ceramic bioactive scaffolds for bone substitutes.

Authors:  C Vitale-Brovarone; E Vernè; M Bosetti; P Appendino; M Cannas
Journal:  J Mater Sci Mater Med       Date:  2005-10       Impact factor: 3.896

4.  Macroporous bioactive glass-ceramic scaffolds for tissue engineering.

Authors:  C Vitale Brovarone; E Verné; P Appendino
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

5.  Porous ceramic bone scaffolds for vascularized bone tissue regeneration.

Authors:  Julia Will; Reinhold Melcher; Cornelia Treul; Nahum Travitzky; Ulrich Kneser; Elias Polykandriotis; Raymund Horch; Peter Greil
Journal:  J Mater Sci Mater Med       Date:  2008-02-29       Impact factor: 3.896

6.  Mechanical characterization of dense calcium phosphate bioceramics with interconnected porosity.

Authors:  Y H Hsu; I G Turner; A W Miles
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

Review 7.  Biomaterial selection for tooth regeneration.

Authors:  Zhenglin Yuan; Hemin Nie; Shuang Wang; Chang Hun Lee; Ang Li; Susan Y Fu; Hong Zhou; Lili Chen; Jeremy J Mao
Journal:  Tissue Eng Part B Rev       Date:  2011-10       Impact factor: 6.389

8.  Toward Strong and Tough Glass and Ceramic Scaffolds for Bone Repair.

Authors:  Qiang Fu; Eduardo Saiz; Mohamed N Rahaman; Antoni P Tomsia
Journal:  Adv Funct Mater       Date:  2013-06-13       Impact factor: 18.808

9.  Osteoblast cell response to beta-tricalcium phosphate scaffolds with controlled architecture in flow perfusion culture system.

Authors:  Xiang Li; Dichen Li; Lin Wang; Bingheng Lu; Zhen Wang
Journal:  J Mater Sci Mater Med       Date:  2008-02-19       Impact factor: 3.896

10.  Hydroxyapatite scaffolds processed using a TBA-based freeze-gel casting/polymer sponge technique.

Authors:  Tae Young Yang; Jung Min Lee; Seog Young Yoon; Hong Chae Park
Journal:  J Mater Sci Mater Med       Date:  2010-01-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.